Search Results: keywords:"adverse health effects"

  • S. 4785 — To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.
    Status:Introduced in Senate
    Words:703

    S. 4785, titled the “Responsibility in Drug Advertising Act of 2024”, aims to amend the Federal Food, Drug, and Cosmetic Act to place restrictions on direct-to-consumer drug advertising. It prohibits advertising newly approved drugs to consumers for the first three years...

    Simple Explanation

    S. 4785 is a new rule that wants to stop ads about new medicines on TV or online for the first three years after they are allowed. But if the medicine is good for people's health, an exception can be asked for in the third year.

  • H. R. 1117 — To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.
    Status:Introduced in House
    Words:681

    H. R. 1117 aims to amend the Federal Food, Drug, and Cosmetic Act by restricting the advertising of drugs directly to consumers. The bill prohibits such advertising for the first three years after a drug is approved. However, there is an option for a waiver during the third...

    Simple Explanation

    H. R. 1117 is a rule that says new medicines can't show TV ads or ads to people for three years after they start being used, but they might allow it a little earlier if it's really good for people’s health. If a medicine has bad side effects after it's sold, they can stop its ads anytime.